Podcast: Selecting a CDMO? Know your molecule, know your timeline

With expertise in development and CMC in short supply globally, CDMO choice is absolutely critical for sponsors relying on them to accelerate development pathway, says Pharmatech Associates.

Ahead of November’s CPhI Worldwide event in Frankfurt, Germany, BioProcess Insider hosted a LinkedIn Live discussion with Bikash Chatterjee and Stephanie Gaulding, the respective CEO and MD at drug development consultancy firm Pharmatech Associates about current outsourcing strategies and how to go about selecting a CDMO partner.

Listen to the full discussion, as part of the BioProcess Insider Expression Platform, below, or at Spotify, Apple, or wherever you get your podcasts.